康臣葯業(01681.HK)SK-07注射液獲准開展臨床試驗

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

康臣葯業(01681.HK)SK-07注射液獲准開展臨床試驗

阿思達克 04-16 19:19

康臣葯業(01681.HK)公布，收到國家藥品監督管理局通知，SK-07注射液的臨床試驗申請獲得批准。SK-07為集團和上海藥明康德聯合研發的新一代治療尿毒症瘙癢症一類新藥。

康臣藥業(01681.HK)

Relevant Stocks

康臣藥業(01681.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

康臣葯業(01681.HK)SK-07注射液獲准開展臨床試驗

Services

About Us

Agreement Statement